Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine

Keyphrases

• Personalized Medicine 100%
• Strategies to Overcome 100%
• Financial Problems 100%
• Regulatory Issues 100%
• Molecular Aberrations 50%
• Targeted Agents 50%
• Rapid Learning System 50%
• Clinical Research 25%
• Oncogenesis 25%
• Metastasis 25%
• Clinical Outcomes 25%
• Clinical Practice 25%
• Molecular Data 25%
• Health Systems 25%
• Europe 25%
• In Cancer 25%
• Aberrations 25%
• Drug Development 25%
• Tumor Tissue 25%
• Standards of Practice 25%
• Radiologic 25%
• Academic Center 25%
• Oncology Practice 25%
• Molecular Network 25%
• Knowledge Gaps 25%
• Regulatory Agencies 25%
• Cancer Community 25%
• Clinical Care 25%
• Translational Cancer Research 25%
• Pharmaceutical Companies 25%
• Reimbursement Mechanisms 25%
• Regulatory Standards 25%
• Tissue Acquisition 25%
• Scientific Breakthrough 25%
• Clinical Registry 25%
• Technological Breakthrough 25%
• Material Resources 25%
• Clinical Laboratory Data 25%
• Regulatory Decisions 25%
• Informatics System 25%
• Biologic Materials 25%
• Device Approval 25%
• Technological Resources 25%
• Economic Data 25%
• Healthcare Payment 25%
• Payment Policy 25%
• Innovative Approaches 25%
• Targetable 25%
• Drug Access 25%
• Molecular Testing 25%
• Healthcare Payers 25%
• Health Technology Assessment Organizations 25%
• Device Access 25%
• CancerLinQ 25%
• Electronic Patient Information 25%
• Across Borders 25%

Medicine and Dentistry

• Personalized Medicine 100%
• Health Care 75%
• Malignant Neoplasm 50%
• Cancer Research 25%
• Clinical Study 25%
• Carcinogenesis 25%
• Neoplasm 25%
• Oncology 25%
• Clinical Research 25%
• Biocompatible Material 25%
• Technology Assessment 25%
• Health Technology 25%